Ironwood Pharmaceuticals Inc (IRWD) — Cash Flow-to-Debt Ratio
Ironwood Pharmaceuticals Inc (IRWD) has a Cash Flow-to-Debt Ratio of 0.01x as of March 2026, meaning its operating cash flow of $5.12 Million could theoretically repay 0% of its total liabilities ($651.71 Million) in one year. See Ironwood Pharmaceuticals Inc (IRWD) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Ironwood Pharmaceuticals Inc Cash Flow-to-Debt Ratio (2007–2025)
Historical debt coverage capacity for Ironwood Pharmaceuticals Inc across 19 annual periods. Also explore Ironwood Pharmaceuticals Inc (IRWD) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Ironwood Pharmaceuticals Inc (2007–2025)
Year-by-year debt coverage analysis for Ironwood Pharmaceuticals Inc. For market capitalisation and broader financial context, see Ironwood Pharmaceuticals Inc market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.19x | $127.04 Million | $658.74 Million | ▲ +21.5% |
| 2024 | 0.16x | $103.55 Million | $652.24 Million | ▼ -29.3% |
| 2023 | 0.22x | $183.43 Million | $817.37 Million | ▼ -63.3% |
| 2022 | 0.61x | $273.76 Million | $448.14 Million | ▲ +21.5% |
| 2021 | 0.50x | $261.89 Million | $521.02 Million | ▲ +47.8% |
| 2020 | 0.34x | $168.84 Million | $496.60 Million | ▲ +1472.3% |
| 2019 | 0.02x | $10.72 Million | $496.00 Million | ▲ +116.1% |
| 2018 | -0.13x | $-70.88 Million | $528.42 Million | ▲ +19.7% |
| 2017 | -0.17x | $-99.56 Million | $595.83 Million | ▼ -322.5% |
| 2016 | -0.04x | $-25.43 Million | $643.11 Million | ▲ +80.6% |
| 2015 | -0.20x | $-106.93 Million | $524.00 Million | ▲ +67.9% |
| 2014 | -0.64x | $-155.57 Million | $244.96 Million | ▲ +44.1% |
| 2013 | -1.14x | $-273.36 Million | $240.74 Million | ▼ -40.0% |
| 2012 | -0.81x | $-69.63 Million | $85.86 Million | ▼ -6.9% |
| 2011 | -0.76x | $-75.24 Million | $99.12 Million | ▼ -58.5% |
| 2010 | -0.48x | $-67.90 Million | $141.81 Million | ▼ -5418.3% |
| 2009 | -0.01x | $-4.00 Million | $460.79 Million | ▲ +88.6% |
| 2008 | -0.08x | $-28.20 Million | $371.13 Million | ▼ -253.2% |
| 2007 | -0.02x | $-6.76 Million | $314.28 Million | — |